Javascript must be enabled to continue!
Appearance of Platelet-Clumping Substance after Acidification of Plasma
View through CrossRef
Abstract
1. The pH values of heparinized plasma from ten normal rabbits were from 7.53 to 7.80. The average pH and standard error was 7.69 ± 0.03. These plasmas did not show platelet-clumping activity when exposed to the platelet-saline suspension from the same or other normal rabbits. The platelet-clumping substance was not observed in all ten cases after alkalinization of the plasma to pH values ranging from 8.32 to 9.40. On the contrary, immediately after acidification of the plasmas, the platelet-clumping substance appeared at pH values from 4.90 to 6.82 at room temperature. The range of the lower pH value, in which the platelet-clumping substance was observed, was 4.90-5.60 (5.15 ± 0.07 in average) and the upper range was 5.95-6.82 (6.27 ± 0.12 in average). The pH range at which the strongest clumping of platelets appeared was 5.22-5.95 (5.61 ± 0.07 in average). The platelet-clumping substance did not disappear after the pH of the acidified plasma was reneutralized to the original value.
2. No clumping was found after the addition of citrated, oxalated, EDTA-plasma or serum even when they were acidified. After the pH value of the citrated, oxalated or EDTA-plasma was changed from 4.85 ± 0.39 to 7.55 ± 0.03 and in the presence of calcium ions (10 mM.), platelet-clumping activity was observed. After the addition of citrate (0.38 percent in final concentration), oxalate (0.2 percent in final concentration), or EDTA (0.1 percent in final concentration) to the heparinized plasma the platelet-clumping substance did not disappear. In the case of serum, the platelet-clumping activity did not appear after the pH changes.
3. The platelet-clumping substance in the acidified plasma was heat-labile; it was detected after BaSO4-adsorption and defibrination; it was stable in storage at 4 C., and it was not dialyzable against Ringer’s solution for 72 hours. It induced platelet clumping not only in citrated platelet-rich plasma but also in the platelet-saline suspension.
4. The properties of the platelet-clumping substance in the acidified plasma were compared with that of substances known to have platelet-clumping activity and the experimental evidences showing the differences to ADP, thrombin, ADP-cofactor and thrombocyte agglutinating factors have been detailed.
American Society of Hematology
Title: Appearance of Platelet-Clumping Substance after Acidification of Plasma
Description:
Abstract
1.
The pH values of heparinized plasma from ten normal rabbits were from 7.
53 to 7.
80.
The average pH and standard error was 7.
69 ± 0.
03.
These plasmas did not show platelet-clumping activity when exposed to the platelet-saline suspension from the same or other normal rabbits.
The platelet-clumping substance was not observed in all ten cases after alkalinization of the plasma to pH values ranging from 8.
32 to 9.
40.
On the contrary, immediately after acidification of the plasmas, the platelet-clumping substance appeared at pH values from 4.
90 to 6.
82 at room temperature.
The range of the lower pH value, in which the platelet-clumping substance was observed, was 4.
90-5.
60 (5.
15 ± 0.
07 in average) and the upper range was 5.
95-6.
82 (6.
27 ± 0.
12 in average).
The pH range at which the strongest clumping of platelets appeared was 5.
22-5.
95 (5.
61 ± 0.
07 in average).
The platelet-clumping substance did not disappear after the pH of the acidified plasma was reneutralized to the original value.
2.
No clumping was found after the addition of citrated, oxalated, EDTA-plasma or serum even when they were acidified.
After the pH value of the citrated, oxalated or EDTA-plasma was changed from 4.
85 ± 0.
39 to 7.
55 ± 0.
03 and in the presence of calcium ions (10 mM.
), platelet-clumping activity was observed.
After the addition of citrate (0.
38 percent in final concentration), oxalate (0.
2 percent in final concentration), or EDTA (0.
1 percent in final concentration) to the heparinized plasma the platelet-clumping substance did not disappear.
In the case of serum, the platelet-clumping activity did not appear after the pH changes.
3.
The platelet-clumping substance in the acidified plasma was heat-labile; it was detected after BaSO4-adsorption and defibrination; it was stable in storage at 4 C.
, and it was not dialyzable against Ringer’s solution for 72 hours.
It induced platelet clumping not only in citrated platelet-rich plasma but also in the platelet-saline suspension.
4.
The properties of the platelet-clumping substance in the acidified plasma were compared with that of substances known to have platelet-clumping activity and the experimental evidences showing the differences to ADP, thrombin, ADP-cofactor and thrombocyte agglutinating factors have been detailed.
Related Results
Acid Mucopolysaccharides As Cofactor in Formation of Platelet-clumping Substance
Acid Mucopolysaccharides As Cofactor in Formation of Platelet-clumping Substance
Abstract
Incubation at 37°C for 30 min or the addition of CaCl2 (5 mM) generated platelet-clumping activity in citrated plasma and EDTA plasma previously acidified t...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
PREPARATION AND IN VITRO WOUND HEALING EFFECTS OF ANIMAL-BASED PLATELET-RICH PLASMA LYSATE
PREPARATION AND IN VITRO WOUND HEALING EFFECTS OF ANIMAL-BASED PLATELET-RICH PLASMA LYSATE
Wound healing is a vital field of study in both human and veterinary medicine, particularly in the treatment of chronic wounds. Platelet-rich plasma, known for its potential to enh...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Plasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect of aspi...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposition following an enviro...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Abstract
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposi...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
AbstractPlasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect...
Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)
Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)
Abstract
Background: Primary immune Thrombocytopenia (ITP) is an acquired autoimmune hemorrhagic disorder characterized ...

